CD22 is expressed on B lymphocytes. It can be used as an alternative B-cell marker to CD20 or CD79a. Diagnostically, CD22 is useful to confirm B-cell lineage in malignant lymphomas.
No special preparation is needed for CD 22 Count Immunohistochemistry Biopsy Tissue. Inform your doctor if you are on any medications or have any underlying medical conditions or allergies before undergoing CD 22 Count Immunohistochemistry Biopsy Tissue. Your doctor depending on your condition will give specific instructions.
|UNISEX||All age groups||Test is positive if the conditions listed are detected|